Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionTRUE Private Wealth Advisors
Latest Disclosed Ownership10,083 shares
Latest Disclosed Value $ 611,557
TRUE Private Wealth Advisors reports 1.49% decrease in ownership of BRM / Bristol-Myers Squibb Company

On May 15, 2026 - TRUE Private Wealth Advisors filed a 13F-HR form disclosing ownership of 10,083 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $528,551 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 10,236 shares of Bristol-Myers Squibb Company. This represents a change in shares of -1.49% during the quarter. The current value of the position is $478,237 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 10,083 -153 -1.49 612 10.69 0.0583
2026-02-13 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 10,236 103 1.02 552 20.79 0.0553
2025-11-14 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 10,133 -905 -8.20 457 -10.39 0.0466
2025-08-11 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 11,038 1,477 15.45 511 -12.52 0.0574
2025-05-15 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 9,561 348 3.78 583 11.90 0.0708
2025-02-13 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 9,213 -125 -1.34 521 7.87 0.0633
2024-11-14 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 9,338 -4,069 -30.35 483 -13.13 0.0576
2024-07-16 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 13,407 -996 -6.92 557 -28.81 0.0630
2024-04-25 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 14,403 645 4.69 781 10.78 0.0896
2024-01-30 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 13,758 -48,125 -77.77 706 -80.37 0.0893
2023-11-13 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 61,883 6,661 12.06 3,592 1.70 0.4988
2023-08-11 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 55,222 1,165 2.16 3,531 -5.74 0.5217
2023-05-11 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 54,057 -457 -0.84 3,747 -4.49 0.5543
2023-02-14 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 54,514 782 1.46 3,922 2.70 0.6040
2022-11-04 2022-09-30 13F BRISTOLMYERS SQUIBB CO COM COM 110122108 53,732 2,920 5.75 3,819 -2.38 0.5780
2022-07-28 2022-06-30 13F BRISTOLMYERS SQUIBB CO COM COM 110122108 50,812 1,328 2.68 3,912 3.60 0.5692
2022-05-09 2022-03-31 13F BRISTOLMYERS SQUIBB CO COM COM 110122108 49,484 39,940 418.48 3,776 534.62 0.5313
2022-02-11 2021-12-31 13F BRISTOL MYERS SQUIBB CO COM COM 110122108 9,544 -533 -5.29 595 -1.00 0.0847
2021-11-05 2021-09-30 13F Bristol Myers Squibb COM 110122108 10,077 -596 -5.58 601 -15.71 0.0875
2021-08-10 2021-06-30 13F Bristol-Myers Squibb COM 110122108 10,673 1,375 14.79 713 20.44 0.1059
2021-05-12 2021-03-31 13F Bristol Myers Squibb COM 110122108 9,298 -4,763 -33.87 592 -32.65 0.0957
2021-01-11 2020-12-31 13F Bristol-Myers Squibb COM 110122108 14,061 -181 -1.27 879 2.45 0.1473
2020-10-09 2020-09-30 13F Bristol-Myers Squibb COM 110122108 14,242 1,035 7.84 858 10.57 0.1466
2020-07-07 2020-06-30 13F Bristol-Myers Squibb COM 110122108 13,207 1,380 11.67 776 17.75 0.1420
2020-04-20 2020-03-31 13F Bristol-Myers Squibb COM 110122108 11,827 -940 -7.36 659 -19.54 0.1403
2020-01-27 2019-12-31 13F Bristol-Myers Squibb COM 110122108 12,767 6,766 112.75 819 169.41 0.1256
2019-10-09 2019-09-30 13F Bristol-Myers Squibb COM 110122108 6,001 1,456 32.04 304 47.57 0.0525
2019-08-01 2019-06-30 13F Bristol-Myers Squibb COM 110122108 4,545 4,545 206 0.0351
2019-01-14 2018-12-31 13F Bristol-Myers Squibb COM 110122108 0 -3,949 -100.00 0 -100.00
2018-10-18 2018-09-30 13F Bristol-Myers Squibb COM 110122108 3,949 3,949 245,128 0.0345
2018-07-13 2018-06-30 13F Bristol-Myers Squibb COM 110122108 0 -5,614 -100.00 0 -100.00
2018-04-25 2018-03-31 13F Bristol-Myers Squibb COM 110122108 5,614 -385 -6.42 355 -3.27 0.0610
2018-01-19 2017-12-31 13F Bristol-Myers Squibb COM 110122108 5,999 349 6.18 367 1.94 0.0636
2017-10-27 2017-09-30 13F Bristol-Myers Squibb COM 110122108 5,650 26 0.46 360 15.02 0.0811
2017-08-07 2017-06-30 13F Bristol-Myers Squibb COM 110122108 5,624 325 6.13 313 10.60 0.0725
2017-04-20 2017-03-31 13F Bristol-Myers Squibb COM 110122108 5,299 206 4.04 283 12.75 0.0647
2017-02-14 2016-12-31 13F Bristol-Myers Squibb COM 110122108 5,093 -160 -3.05 251 -4.56 0.0613
2016-11-08 2016-09-30 13F Bristol Myers Squibb COM 110122108 5,253 -124 -2.31 263 -33.42 0.0843
2016-08-01 2016-06-30 13F Bristol Myers Squibb COM 110122108 5,377 15 0.28 395 15.50 0.1321
2016-06-16 2016-03-31 13F/A-1 Bristol-Myers Squibb COM 110122108 5,362 -572 -9.64 342 -16.18 0.1330
2016-05-11 2016-03-31 13F Bristol-Myers Squibb COM 110122108 5,362 342
2016-03-16 2015-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,934 5,934 408 0.1795
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.